Lidocaine Hydrochloride Mercury Pharmaceuticals

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Mercury Pharmaceuticals, is a local anesthetic (amide type) presented as a sterile injectable solution for epidural, intramuscular, and intravenous use. It provides regional or systemic anesthesia for minor surgical procedures, epidural analgesia, and certain cardiac arrhythmias.

GNH USA supplies Lidocaine Hydrochloride Mercury Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is a local anesthetic that acts on nerve conduction and cardiac tissue. - Minor surgical procedures: provides rapid, reversible loss of sensation to enable pain‑free operations. - Epidural analgesia: delivers regional pain relief during labor, postoperative care, or chronic pain management. - Cardiac arrhythmias: used intravenously to suppress ventricular ectopy and stabilize abnormal heart rhythms.

Lidocaine Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Injection site pain: discomfort at the site of administration. - Transient numbness: temporary loss of sensation beyond the target area. - Tachycardia: increased heart rate during systemic exposure.

Serious or Rare Side Effects: - Seizures: central nervous system excitation with high plasma levels. - Severe hypotension: marked drop in blood pressure, especially with rapid IV injection. - Allergic reactions (anaphylaxis): rare but potentially life‑threatening hypersensitivity.

When using Lidocaine Hydrochloride, clinicians should observe several safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular monitoring: observe for arrhythmias or hypotension during IV administration. - Dosage control: administer only under qualified medical supervision. - Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Lidocaine Hydrochloride can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine): may increase systemic toxicity. - Beta‑blockers: can potentiate bradycardia and hypotension. - CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative toxicity risk when combined. - Diuretics (e.g., furosemide): may enhance hypotensive effect.